Payer & Market Access Expert — Gross-to-Net & Formulary Strategy

DigiNo; United States; Remote; USD 1,033,000 - 2,755,000; Full time

Job summary

Mercor is seeking a US-based payer/market access expert for a paid pilot to develop and critique rubrics analyzing commercial drugs and drug-development programs. This engagement focuses on evaluating gross-to-net, rebates, and formulary-tier assumptions across a selected set of drugs.

The role is remote, US-based, with an expected effort of 10–20 hours over 1–2 weeks. Strong familiarity with biotech/pharma development programs is preferred, with recurring opportunities for strong contributors.

Qualifications

• US-based payer / market access professional
• Familiarity with biotech/pharma development programs
• Hands-on with gross-to-net, rebates, and formulary tiering by drug class

Responsibilities

• Create and critique rubrics that analyze commercial drugs and drug-development programs
• Set and pressure-test gross-to-net and formulary-tier assumptions by drug class
• Judge whether coverage, rebating, and tiering assumptions reflect how payers actually behave
• Apply this across the pilot's set of drugs and drug classes

Skills

payer market access

gross-to-net

formulary-tiering

drug-class analysis

Job description

Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a payer / market access expert for a paid pilot, with the potential to continue as the work scales.

Responsibilities

• Create and critique rubrics that analyze commercial drugs and drug-development programs
• Set and pressure-test gross-to-net and formulary-tier assumptions by drug class
• Judge whether coverage, rebating, and tiering assumptions reflect how payers actually behave
• Apply this across the pilot's set of drugs and drug classes

Requirements

• US-based payer / market access professional
• Familiarity with biotech/pharma development programs
• Hands-on with gross-to-net, rebates, and formulary tiering by drug class
• 5+ years in market access, pricing & reimbursement, or managed markets

Engagement Details

• Duration: Approximately 10–20 hours over a 1–2 week pilot
• Remote — US-based

Why Participate

• Help improve expert AI evaluation of drugs and drug-development programs
• Recurring engagement for strong contributors